Clinical Research has advanced and there are now clinical trials aiming to prevent memory loss before it begins as well as delay the progression.
Learn about the A4 Study that Brain Matters Research is currently running.
Get involved now, before Alzheimer's starts.
Learn more about this study.
One of the largest, most respected private clinical research facilities in the country specializing in Alzheimer's Disease diagnosis, treatment and prevention.
Join our next trial.
Become a part of the Brain Matters family and receive the best disease-modifying medications that are currently being researched.
Find the right clinical trial.
Encouragement. Assistance. Resources. Education.
Whatever it takes, we are here.
Get more information.
We specialize in Central Nervous System (CNS) trials, with an emphasis on Alzheimer’s Disease, for which we are recognized as one of the leading top-tier sites in North America.
Patients receive initial assessments, memory testing and examination at no cost.
We care about you and your quality of life.
Be a participant.
WHAT WE OFFER
Know in 90 - Confidential Comprehensive Evaluations, FREE OF CHARGE
No Insurance Necessary
Cutting Edge Research Opportunities
On-Site Informational seminars & Caregiver Support Groups
Expedited Access to Local Best In-Class Resources
Monthly “Open House Informational Brunch with the Dr.” (RSVP Required) Call us for upcoming dates!
By Alzheimer’s Prevention Bulletin Our October expert is Deborah Blacker, MD, ScD, Professor of Psychiatry at Harvard Medical School and Professor and Deputy Chair, Epidemiology at the Harvard T.H. Chan School of Public Health. Dear Dr. Blacker, I understand that memory games and crossword puzzles are supposed to be good for your brain health. But […]
What’s a 10 Letter Word for Maintaining Your Brain? E-n-g-a-g-e-m-e-n-t For Deborah Blacker, MD, ScD, and her colleagues, brain health and dementia prevention is serious business, but they can sum up a portion of their recent research findings with a humorous anecdote. “A colleague of mine who worked on the study shared this, ‘A patient […]
Watch the recording as Dr. Pierre N. Tariot, Director of the Banner Alzheimer’s Institute, discusses the latest research into Alzheimer’s treatment and prevention. In this recording, he examines what we know about Alzheimer’s, including the role of genes in its development. He also talks about risk factors for the disease, important new studies currently enrolling […]
DRUG TRIAL VIDEO & ARTICLE: See how the investigational new drug, T3D-959, elicited rapid improvement in cognitive tests in 53% of subjects with Alzheimer’s. Look into the exploratory, open label Phase 2a study. In an open-label exploratory study, 36 subjects with mild to moderate disease (MMSE 14-26) were randomized to receive 1 of 4 doses […]
vTv Therapeutics Completes Enrollment of Part A of Pivotal Phase 3 Trial Evaluating Azeliragon for the Treatment of Patients with Mild Alzheimer’s Disease
Phase 2b Trial Showed Positive Results In Slowing Cognitive Decline High Point, North Carolina (September 7, 2016) vTv Therapeutics Inc. (NASDAQ:VTVT) today announced the completion of enrollment for Part A of STEADFAST (Single Trial Evaluating Alzheimer’s Disease Following Addition to Symptomatic Therapy), vTv’s Phase 3 placebo-controlled trial of azeliragon, an oral antagonist of the Receptor […]